IBL pipetting in lab


Research and development forms the foundations of our business, and we are committed to using science to improve the health and wellbeing of New Zealanders.

The development of new healthcare products, life-saving medicines, and vaccines can take up to 12 years, and cost millions of dollars.

GSK believes it is essential to continue seeking the best treatments for today’s health issues, and invests billions of dollars into new research every year.

Around the world, our company employs more than 13,000 people working across R&D. Together with our industry partners in research institutions, academia and government, we work towards providing medicines to the people who need them most.

We believe we can truly make a difference by devoting our company’s vast resources to advanced science, with the aim of improving the health of New Zealanders and people worldwide.

GSK is making great advances in patient care, and easing the burden of disease locally. Currently in New Zealand we have 27 studies being sponsored on topics as diverse as asthma, whooping cough, and coronary heart disease. In 2014-15 alone, we invested $5.17 million into local projects.

Dr Ian Griffiths, Medical Director, GSK NZ

Find out more about our rigorous processes and testing of new medicines and vaccines to ensure their safety and effectiveness.